So. Asbell et al., Prostate-specific antigen and androgens in African-American and white normal subjects and prostate cancer patients, J NAT MED A, 92(9), 2000, pp. 445-449
Prostate cancer in African Americans is more aggressive and common than in
any other racial group. An endocrine mechanism has been proposed to account
for this racial difference. However, androgen levels in African-American e
lderly normal subjects and prostate cancer patients have been insufficientl
y studied. Because the Albert Einstein Medical Center (AEMC) has a large Af
rican-American population, we could contribute racial data from which obser
vations could be made within this study and in past and future studies.
Blood from 38 screened men (mean age 65) with prostate-specific antigen (PS
A) less than 4 ng/mL and normal rectal examination seen at the AEMC Cancer
Center was studied using standard radioimmunoassays. The blood samples also
served as our control. Our experimental group consisted of 51 prostate can
cer patients (mean age 71 years), all of whom had nonmetastatic prostate ca
ncer. Subjects were categorized by cancer status, race, and age group.
In our screened subjects, PSA, testosterone, and dihydrotestosterone were n
ot higher in African Americans than in whites. Furthermore, our prostate ca
ncer patients demonstrated no significant racial variation for PSA, testost
erone, and dihydrotestosterone. Our data also did not indicate any correlat
ion between PSA and androgen levels in our cancer patients.
In our population of elderly men, no racial differences in androgen levels
were found. Androgen levels did not correlate with PSA levels in prostate c
ancer patients.